<DOC>
	<DOCNO>NCT01888003</DOCNO>
	<brief_summary>The goal study gain insight comparative effectiveness treat patient , find anemic elective surgery , series weekly subcutaneous dos drug give surgery , stimulate natural production red blood cell ( so-called erythropoietic stimulating agent [ ESA ] ) along intravenous iron , reduce need blood transfusion ( donate someone patient ) adult total hip arthroplasty ( hip replacement surgery ) . The effect Preoperative Anemia Management Program ( PAMP ) patient 's quality recovery , health-related quality life , fatigue , rehabilitation pattern surgery also examine . A cost-effectiveness analysis perform compare cost commercially available , FDA-approved medication versus cost transfuse blood</brief_summary>
	<brief_title>The Benefits Preoperative Anemia Management Program</brief_title>
	<detailed_description>Patient blood management ( PBM ) involve timely conscientious use current best evidence make medical surgical decision care patient maintain red blood cell level , optimize blood clotting , minimize blood loss , effort improve patient outcome . PBM focus treatment individual patient comprise transfusion therapy drug therapy . PBM base three point : ( 1 ) optimization ( preoperative ) red blood cell volume , ( 2 ) reduction diagnostic , therapeutic , intraoperative blood loss , ( 3 ) increase individual tolerance towards anemia accurate blood transfusion trigger . PBM primarily identify patient risk transfusion provide management plan aim reduce eliminate anemia need blood transfusion donate someone patient ( allogeneic transfusion ) , thus reduce risk , blood bank inventory pressure , escalate cost associated transfusion . The implementation formal UAB Preoperative Anemia Management Program ( PAMP ) may help achieve consistent PBM . Efforts make coordinate patient ' schedule surgery date initial evaluation UAB Highlands Hospital Preoperative Assessment , Consultation , Treatment ( HPACT ) Clinic , first PACT Clinic visit occur approximately 14 day prior plan total hip replacement total knee replacement</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>1 . 19 year 80 year age 2 . American Society Anesthesiologists 13 status 3 . Undergoing total hip arthroplasty osteoarthritis , ( either primary replacement procedure , revision procedure ) OR avascular necrosis ( AVN ) ; OR undergoing total knee arthroplasty ( replacement ) osteoarthritis 1 . American Society Anesthesiologists 4 status 2 . Severe anemia , define hematocrit &lt; 30 % 3 . History hypercoagulability thrombophilia ( e.g , factor V Leiden ) 4 . History deep venous thrombosis ( DVT ) venous thromboembolism ( VTE ) within last 12 month 5 . Current use anticoagulant ( e.g. , heparin , warfarin , dabigatran , etc ) 6 . Diagnosis chronic renal insufficiency require dialysis 7 . Morbid obesity ( BMI &gt; 40 ) 8 . History allergic reaction intravenous iron 9 . History allergic reaction erythropoietic stimulating agent ( ESA ) 10 . History sickle cell disease 11 . History hemochromatosis 12 . History liver dysfunction congestive heart failure 13 . History substance abuse disorder 14 . History major psychiatric disorder ( e.g. , major depression , bipolar disorder , axis II personality disorder , schizophrenia ) 15 . Uncontrolled hypertension ( define systolic pressure ≥ 160 mmHg and/or diastolic pressure ≥ 110 mmHg ) 16 . History uncontrolled cardiac arrhythmia , cerebrovascular accident ( CVA ) , transient ischemic attack ( TIA ) , acute coronary syndrome ( ACS ) , arterial thrombosis . ACS include unstable angina , Q wave myocardial infarction ( QwMI ) , nonQ wave myocardial infarction ( NQMI ) within 6 month 17 . History pure red cell aplasia ( PRCA ) treatment ESA 18 . History seizure disorder 19 . Any active/current cancer within last 12 month ( include nonmelanoma skin cancer ) 20 . Pregnancy lactation 21 . Nonnative English speaker ( validated Spanish language version two patient questionnaire available )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>anemia</keyword>
</DOC>